Pivhydrazine
Pivhydrazine (trade name Tersavid), also known as pivalylbenzhydrazine and pivazide, is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was formerly used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]
 | |
| Clinical data | |
|---|---|
| Other names | Angorvid, Betamezid, Neomarsilid, Pivazide, Pivhydrazine |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.620  |
| Chemical and physical data | |
| Formula | C12H18N2O |
| Molar mass | 206.289 g·mol−1 |
| |
| (verify) | |
See also
References
- Herman ZS, Sokola A, Lenartowicz H, Zieliński M, Depta L (May–June 1976). "The influence of antidepressive drugs on the level of acetylcholine and on the acetylcholinesterase activity in the brain of rats". Polish Journal of Pharmacology and Pharmacy. 28 (4): 313–21. OCLC 1586290. PMID 981020.
- Bolton GC, Griffiths LA (November–December 1979). "The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat". Drug Metabolism and Disposition. 7 (6): 388–92. OCLC 1784380. PMID 43225.
- Mikhaĭlova TV, Gilev AP, Khavronina-Gureeva ZP (1969). "[Central effects of betamezide]". Farmakologiia I Toksikologiia (in Russian). 32 (6): 652–6. OCLC 1568906. PMID 5381593.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.